RÉDOVÁ, Martina, Jaroslav MICHÁLEK and Ondřej SLABÝ. MicroRNAs and Renal Cell Carcinoma. In Ondrej Slaby. MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets. New York: Nova Science Publishers, Inc., 2012, p. 121-128. ISBN 978-1-61324-514-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MicroRNAs and Renal Cell Carcinoma
Authors RÉDOVÁ, Martina (203 Czech Republic, guarantor, belonging to the institution), Jaroslav MICHÁLEK (203 Czech Republic) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution).
Edition New York, MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets, p. 121-128, 8 pp. 2012.
Publisher Nova Science Publishers, Inc.
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
RIV identification code RIV/00216224:14740/12:00060173
Organization unit Central European Institute of Technology
ISBN 978-1-61324-514-9
Keywords in English microRNAs; renal cell carcinoma
Tags ok, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 19/3/2013 08:56.
Abstract
Renal cell carcinoma (RCC) is the most common neoplasm of the adult kidney accounting for about 3 % of adult malignancies. As the role of miRNAs in RCC pathogenesis is emerging, it has been postulated that miRNAs can serve as new potential biomarkers that may improve diagnostic, prognostic and predictive abilities, and consequently, the management of RCC patients.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 26/4/2024 12:18